TEMGESIC buprenorphine 200 microgram (as hydrochloride) sublingual tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

temgesic buprenorphine 200 microgram (as hydrochloride) sublingual tablet blister pack

echo therapeutics pty ltd - buprenorphine hydrochloride, quantity: 0.216 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; mannitol; maize starch; povidone; magnesium stearate; citric acid; sodium citrate dihydrate - temgesic sublingual tablets are indicated for the short-term (not more than one week) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. temgesic is not recommended for use in children. temgesic does not have an approved role in opioid dependence rehabilitation programmes.

TEMGESIC buprenorphine 200 microgram (as hydrochloride) sublingual tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

temgesic buprenorphine 200 microgram (as hydrochloride) sublingual tablet bottle

echo therapeutics pty ltd - buprenorphine hydrochloride, quantity: 0.216 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; mannitol; maize starch; povidone; magnesium stearate; citric acid; sodium citrate dihydrate - temgesic sublingual tablets are indicated for the short-term (not more than one week) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. temgesic is not recommended for use in children. temgesic does not have an approved role in opioid dependence rehabilitation programmes.

Temgesic 400microgram sublingual tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

temgesic 400microgram sublingual tablets

eumedica pharmaceuticals ag - buprenorphine hydrochloride - sublingual tablet - 400microgram

Temgesic 200microgram sublingual tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

temgesic 200microgram sublingual tablets

eumedica pharmaceuticals ag - buprenorphine hydrochloride - sublingual tablet - 200microgram

Temgesic 200 microgram Sublingual Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

temgesic 200 microgram sublingual tablets

indivior europe limited - buprenorphine hydrochloride - sublingual tablet - 0.2 base milligrams - oripavine derivatives; buprenorphine

Temgesic 200 microgram Sublingual Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

temgesic 200 microgram sublingual tablets

eumedica pharmaceuticals gmbh - buprenorphine hydrochloride - sublingual tablet - oripavine derivatives; buprenorphine

TEMGESIC SUBLINGUAL TABLET 0.2 mg Singapore - English - HSA (Health Sciences Authority)

temgesic sublingual tablet 0.2 mg

zuellig pharma pte. ltd. - buprenorphine hcl eqv buprenorphine - tablet - 0.2 mg - buprenorphine hcl eqv buprenorphine 0.2 mg

TEmgESIC SUBLINGUAL TABLETS South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

temgesic sublingual tablets

adcock ingram critical care (pty) ltd - tablet - see ingredients - each tablet contains buprenorphine hydrochloride equivalent to buprenorphine 0,2 mg

Temgesic Sublingualis 0.2 mg subl. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

temgesic sublingualis 0.2 mg subl. tabl.

eumedica pharmaceuticals gmbh - buprenorphine hydrochloride 0,22 mg - eq. buprenorphine 0,2 mg - sublingual tablet - 0,2 mg - buprenorphine hydrochloride 0.22 mg - buprenorphine

Temgesic Sublingual Tablets Australia - English - Department of Health (Therapeutic Goods Administration)

temgesic sublingual tablets

reckitt benckiser pty ltd - buprenorphine hydrochloride -